SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
DC 20549
__________________
FORM
8-K
CURRENT
REPORT
PURSUANT
TO SECTION 13 OR 15(d) OF THE
SECURITIES
EXCHANGE ACT OF 1934
Date
of
Report (Date of earliest event reported):
May 14,
2008
THE
FEMALE HEALTH COMPANY
|
(Exact
name of registrant as specified in its charter)
|
Wisconsin
|
(State
or other jurisdiction of incorporation)
|
1-13602
|
|
39-1144397
|
(Commission
File Number)
|
|
(I.R.S.
Employer I.D. Number)
|
515
North State Street
Suite
2225
Chicago,
Illinois
|
|
60610
|
(Address
of Principal Executive Offices)
|
|
(Zip
Code)
|
312-595-9123
|
(Registrant's
telephone number, including area code)
|
Check
the appropriate box below if the
Form 8-K filing is intended to simultaneously satisfy the filing obligation
of
the registrant under any of the following provisions (
see
General Instruction
A.2.
below):
o
Written
communications pursuant to Rule 425 under the Securities Act
(17
CFR230.425)
o
Soliciting
material pursuant to Rule 14a-12 under the Exchange
Act
(17
CFR
240.14a-12)
o
Pre-commencement
communications pursuant to Rule 14d-2(b)
under the
Exchange
Act (17 CFR 240.14d-2(b))
o
Pre-
commencement
communications pursuant to Rule 13e-4(c) under the
Exchange
Act (17 CFR 240.13e-4(c))
Section
2 – Financial Information
Item
2.02 Results of Operations and Financial
Condition
On
May 14, 2008, The Female Health
Company issued a press release (the "Press Release") announcing results for
the
quarter and six months ended March 31, 2008. A copy of the Press
Release is attached as Exhibit 99.1 to this report. The attached
Exhibit 99.1 is furnished pursuant to Item 2.02 of
Form 8-K.
The
information in this Form 8-K and
the Exhibit attached hereto shall not be deemed "filed" for purposes of Section
18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated
by reference in any filing under the Securities Act of 1933 or the Securities
Exchange Act of 1934, except as shall be expressly set forth by specific
reference in such filing.
Section
9 – Financial Statements and Exhibits
Item
9.01 Financial Statements and Exhibits
(d)
Exhibits
The
following exhibit is furnished herewith:
Exhibit 99.1
– Press Release of The Female Health Company, issued May 14,
2008.
SIGNATURES
Pursuant
to the requirements of the
Securities Exchange Act of 1934, the registrant has duly caused this report
to
be signed on its behalf by the undersigned hereunto duly authorized.
THE
FEMALE HEALTH COMPANY
Date: May 14,
2008
BY
/
s/
Donna
Felch
D
onna
Felch, Vice President and
Chief
Financial Officer
3